AKT PROTEIN KINASE INHIBITORS
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the c...
Saved in:
Main Authors | , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
23.12.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer. |
---|---|
AbstractList | The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer. |
Author | PISCOPIO ANTHONY SPENCER KEITH L STENGEL PETER BLAKE JAMES JOSEY JOHN RAO CHANG BERNACKI APRIL L WANG BIN MILLER SCOTT XIAO DENGMING MITCHELL IAN S XU RIU MUNSON MARK VIGERS GUY P. A KALLAN NICHOLAS C HAN YONGXIN |
Author_xml | – fullname: MILLER SCOTT – fullname: XIAO DENGMING – fullname: BLAKE JAMES – fullname: PISCOPIO ANTHONY – fullname: XU RIU – fullname: WANG BIN – fullname: SPENCER KEITH L – fullname: MUNSON MARK – fullname: VIGERS GUY P. A – fullname: MITCHELL IAN S – fullname: RAO CHANG – fullname: HAN YONGXIN – fullname: JOSEY JOHN – fullname: KALLAN NICHOLAS C – fullname: STENGEL PETER – fullname: BERNACKI APRIL L |
BookMark | eNrjYmDJy89L5WSQdfQOUQgI8g9x9fRT8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx3kFGBoaGBobG5hbGFo7GxKkCAPPmI7k |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | KR20110137838A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_KR20110137838A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:55:43 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_KR20110137838A3 |
Notes | Application Number: KR20117028995 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111223&DB=EPODOC&CC=KR&NR=20110137838A |
ParticipantIDs | epo_espacenet_KR20110137838A |
PublicationCentury | 2000 |
PublicationDate | 20111223 |
PublicationDateYYYYMMDD | 2011-12-23 |
PublicationDate_xml | – month: 12 year: 2011 text: 20111223 day: 23 |
PublicationDecade | 2010 |
PublicationYear | 2011 |
RelatedCompanies | ARRAY BIOPHARMA, INC |
RelatedCompanies_xml | – name: ARRAY BIOPHARMA, INC |
Score | 2.7956898 |
Snippet | The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | AKT PROTEIN KINASE INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111223&DB=EPODOC&locale=&CC=KR&NR=20110137838A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFPVNpzJ1k4LSt-C6tF33UGT9RetYW7oqextp04IobriK_77XsOqe9hYSuCQHl-_ukvsC8DDQOFd4xoleDjSilnxIWJYppKC5pjGVclWQPc9C3X9RnxfaogUfTS2M4An9EeSIaFE52nslzuv1fxLLEW8rN4_ZG3atnrzUdGTepPsUhDvZsUw3jpzIlm3bnCZymIixml3PoMbkAA7RkR7V9uC-WnVdynoXVLwzOIpR3md1Dq33VQdO7ObvtQ4cz7ZX3tjcWt_mAvrokElxEqVuEEoYdk_mrhSEfmAFaZTML-Hec1PbJzjP8m9by2myuyh6BW0M-IsuSKqRl6hCvURnRh1zxlip0WI01hnqE9HlGnr7JN3sH76FU5EXVYZkSHvQrr6-iz4Ca5XdCX38AjOCeE8 |
link.rule.ids | 230,309,783,888,25576,76882 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq-Kj1YCSW7B5mh6CNC8S0zxIo_RWNtkERLHFRvz7TpZGe-pt2YHZ3YHZeezONwD3I5VSkeZU0KqRKigVlQSS56JQyoWqEkWmCgN7DiPNe1Ge5-q8Ax9tLQzDCf1h4IioUQXqe83u69V_EstmfyvXD_kbTi2f3Mywedqm-0Q0d7xtGk4S27HFW5YRpHyUMlqDrqfL-mQP9tHJ1pt-B86r2dSlrLaNinsMBwny-6xPoPO-7EPPanuv9eEw3Dx543CjfetTGKJDxiVpnDl-xGHYPZk5nB95vulncTo7gzvXySxPwHUWf8daBOn2puRz6GLAX14Ap-hFhSLUKnRmlDElhFSqXD6ONYLyROtyCYNdnK52k2-h52XhdDH1o-AajliOVJQESR5At_76LodoZOv8hsnmF_9nez8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=AKT+PROTEIN+KINASE+INHIBITORS&rft.inventor=MILLER+SCOTT&rft.inventor=XIAO+DENGMING&rft.inventor=BLAKE+JAMES&rft.inventor=PISCOPIO+ANTHONY&rft.inventor=XU+RIU&rft.inventor=WANG+BIN&rft.inventor=SPENCER+KEITH+L&rft.inventor=MUNSON+MARK&rft.inventor=VIGERS+GUY+P.+A&rft.inventor=MITCHELL+IAN+S&rft.inventor=RAO+CHANG&rft.inventor=HAN+YONGXIN&rft.inventor=JOSEY+JOHN&rft.inventor=KALLAN+NICHOLAS+C&rft.inventor=STENGEL+PETER&rft.inventor=BERNACKI+APRIL+L&rft.date=2011-12-23&rft.externalDBID=A&rft.externalDocID=KR20110137838A |